Less is More: A Comparison of Antibody-Gold Nanoparticle Conjugates of Different Ratios. 2017

Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
A.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences , Moscow 119071, Russia.

This comprehensive study is related to gold nanoparticles (GNPs) conjugated with antibodies. The goal of the study is to determine the minimal concentration of antibodies for conjugate synthesis when the conjugates have high antigen-capturing activity. Two systems were studied: gold nanoparticles conjugated with monoclonal antibodies (mAb-GNP) specific to Helicobacter pylori and gold nanoparticles conjugated with polyclonal antibodies (pAb-GNP) specific to mouse immunoglobulins. Several conjugates were synthesized with different GNP-to-antibody molar ratios (from 1:1 to 1:245) through nondirectional and noncovalent immobilization on a surface of GNPs with a diameter of 25.3 ± 4.6 nm. The maximal antigen-capturing activities and equilibrium constants of the conjugates correlate with the formation of a constant hydrodynamic radius of the conjugates for mAb-GNP (GNP to antibody molar ratio 1:58) and with the stabilizing concentration by flocculation curves for pAb-GNP (GNP to antibody molar ratio 1:116). The application of the conjugates to the lateral flow immunoassay shows that the antibody concentrations used for the conjugation can be reduced (below the stabilizing concentration) without losing activity for the mAb-GNP conjugates. The findings highlight that the optimal concentration of antibodies immobilized on the surface of GNPs is not always equal to the stabilizing concentration determined by the flocculation curve.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053768 Metal Nanoparticles Nanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver. Metal Nanocrystals,Metallic Nanocrystals,Metallic Nanoparticles,Metal Nanocrystal,Metal Nanoparticle,Metallic Nanocrystal,Metallic Nanoparticle,Nanocrystal, Metal,Nanocrystal, Metallic,Nanocrystals, Metal,Nanocrystals, Metallic,Nanoparticle, Metal,Nanoparticle, Metallic,Nanoparticles, Metal,Nanoparticles, Metallic
D055910 Antibodies, Immobilized Antibodies that are chemically bound to a substrate material which renders their location fixed. Immobilized Antibodies

Related Publications

Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
March 2006, Journal of the American Chemical Society,
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
January 2023, Mikrochimica acta,
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
January 2012, Methods in molecular biology (Clifton, N.J.),
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
December 2010, Chemical communications (Cambridge, England),
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
December 2003, Angewandte Chemie (International ed. in English),
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
February 2017, Aesthetic plastic surgery,
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
January 1981, Immunobiology,
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
February 2021, Molecular imaging and biology,
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
November 2014, Colloids and surfaces. B, Biointerfaces,
Nadezhda A Byzova, and Irina V Safenkova, and Elvira S Slutskaya, and Anatoly V Zherdev, and Boris B Dzantiev
August 2002, Current protocols in nucleic acid chemistry,
Copied contents to your clipboard!